Early Human Development 2000: Vol 59 Index

7 Pages·2000·0.87 MB·English

Early Human Development 59 (2000) 219
www.elsevier.com/locate/earlhumdev
Author index
Volume 59 (2000)
Andersson, Y. 59, 95 Higglof, B. 59, 13 Pramila, S. 59, 61
Anttila, M. 59, 61 Hartikainen, A.-L. 59, 61
Hartnoll, G. 59, 201 Quinn, M.W. 59, 27
Baumgartner, R. 59, 51 Hepper, P.G. 59, 85
Beech, D.J. 59, 193 Hernell, O. 59, 95 Roberts, LA.G. 59, |
Bétrémieux, P. 59, 201 Hoécky, M. 59, 107 Rosenfeld, C.R. 59, 37
Brandt, I. 59, 107 Howard, CNV. 59, 193
Saito, N. 59, 151
Browne, C.A. 59, 209
Seiler, M. 59, 51
Bucher, H.U. 59, 51 Jeffery, H. 59, 127
Sibbons, P.D. 59, 193
Bucher, N. 59, 51 Jeng, S.-F. 59, 159
Siddiqui, A. 59, 13
Sticker, E.J. 59, 107
Calhoun, D.A. 59, 77 Kato, I. 59, 151
Chen, L.-C. 59, 159 Koivisto, M. 59, 61 Togari, H. 59, 151
Chen, P.-S. 59, 159
Christensen, R.D. 59, 77 Lagerqvist, C. 59, 95 Vaaraismaki, M.S. 59, 61
Colditz, P.B. 59, 209 LeFlore, J.L. 59, 37 van Velzen, D. 59, 193
Lentze, M.J. 59, 107 Verloove-Vanhorick, S.P. 59,
den Ouden, A.L. 59, 175 Liao, H.-F. 59, 159 175
Doherty, N.N. 59, 85 Lindquist, S. 59, 95 Vokes, A. 59, 27
Dunster, K.R. 59, 209
Midgley, J. 59, 201 Walther, F.J. 59, 175
Edstrom, C.S. 59, 77 Modi, N. 59, 201 Watts, T.L. 59, |
Engle, W.D. 59, 37 Murray, N.A. 59, |
Yamaguchi, N. 59, 151
Fauchére, J.C. 59, 51 Page, M. 59, 127 Yau, K.-I.T. 59, 159
PII: $0378-3782(00)00109-2

Early Human
Development
Early Human Development 59 (2000) 221-223
www.elsevier.com/locate/earlhumdev
Subject index
Volume 59 (2000)
Abnormal neurologic signs (ANS); AGA; Extracellular fluid volume; Sodium excretion;
Neurologic development; Preterm infants; Re- Atrial natriuretic peptide; Preterm newborns 59,
covery rate; SGA; Transient abnormal neurologic 201
signs (TANS); VLBW 59, 107
Fetuses; Habituation; Maternal diabetes 59, 85
AGA; Abnormal neurologic signs (ANS); Neuro-
Fetus; Thrombopoietin; Newborn 59, |
logic development; Preterm infants; Recovery
rate; SGA; Transient abnormal neurologic signs
Fetus; Tissue factor pathway inhibitor (TFPI);
(TANS); VLBW 59, 107
Tissue factor (TF); Placenta; Coagulation 59, 77
Antenatal steroids; Neonatal blood pressure;
Follow-up; Very preterm infants; Development;
Very low birth weight; Intracranial hemorrhage;
Disorders 59, 175
Volume expansion; Pressor therapy 59, 37
Fungal infections; Human milk; Lactoferrin;
Apparent life-threatening events; Sudden Infant
Skin care; Neonatal care 59, 95
Death syndrome; Gastro-oesophageal reflux 59,
127 Gastro-oesophageal reflux; Sudden Infant Death
syndrome; Apparent life-threatening events 59,
Atrial natriuretic peptide; Sodium excretion; 127
Preterm newborns: Extracellular fluid volume
59, 201 Habituation; Fetuses; Maternal diabetes 59, 85
Autonomic function; Maternal smoking; Head- Head-up tilt; Maternal smoking; Autonomic
up tilt; SIDS 59, 209 function; SIDS 59, 209
Coagulation; Tissue factor pathway inhibitor Human infant; Sleep; Prone/supine position;
(TFPI); Tissue factor (TF); Fetus; Placenta 59, SIDS 59, 151
77
Human milk; Lactoferrin: Skin care; Neonatal
Congenital malformation; Diabetic pregnancy; care; Fungal infections 59, 95
Neonatal morbidity; Perinatal mortality 59, 61
Intracranial hemorrhage; Neonatal blood pres-
Development; Very preterm infants; Follow-up; sure; Very low birth weight; Antenatal steroids;
Disorders 59, 175 Volume expansion; Pressor therapy 59, 37
Diabetic pregnancy; Congenital malformation; Lactoferrin; Human milk; Skin care: Neonatal
Neonatal morbidity; Perinatal mortality 59, 61 care; Fungal infections 59, 95
Disorders; Very preterm infants; Development; Lung development; Organ development; Termi-
Follow-up 59, 175 nal bronchiolar duct endings 59, 193
PII: $0378-3782(00)00110-9
Subject index
Maternal diabetes; Habituation; Fetuses 59, 85 Pressor therapy; Neonatal blood pressure; Very
low birth weight; Intracranial hemorrhage; An-
Maternal role: Prenatal attachment: Maternal tenatal steroids; Volume expansion 59, 37
sensitivity; Mother—infant interaction 59, 13
Preterm infants; Abnormal neurologic signs
Maternal sensitivity; Prenatal attachment; Ma- (ANS); AGA; Neurologic development; Re-
ternal role; Mother—infant interaction 59, 13 covery rate; SGA; Transient abnormal neurologic
signs (TANS); VLBW_ 59, 107
Maternal smoking; Autonomic function; Head-
up tilt; SIDS 59, 209 Preterm newborns; Sodium excretion; Atrial
natriuretic peptide; Extracellular fluid volume
Morphine-6-glucuronide; Pre-term; Morphine;
59, 201
Respiration 59, 27
Prone/supine position; Human infant; Sleep;
Morphine; Pre-term; Morphine-6-glucuronide;
SIDS 59, 151
Respiration 59, 27
Recovery rate; Abnormal neurologic signs
Mother-infant interaction; Prenatal attachment;
(ANS); AGA; Neurologic development; Preterm
Maternal role; Maternal sensitivity 59, 13
infants; SGA; Transient abnormal neurologic
signs (TANS); VLBW 59, 107
Motor development; Prematurity; Risk factor;
Walking 59, 159
Respiration; Pre-term; Morphine; Morphine-6-
glucuronide 59, 27
Neonatal blood pressure; Very low birth weight;
Intracranial hemorrhage; Antenatal steroids; Vol-
Risk factor; Motor development; Prematurity;
ume expansion; Pressor therapy 59, 37
Walking 59, 159
Neonatal care; Human milk; Lactoferrin; Skin
SGA; Abnormal neurologic signs (ANS); AGA;
care; Fungal infections 59, 95
Neurologic development; Preterm infants; Re-
covery rate; Transient abnormal neurologic signs
Neonatal morbidity; Congenital malformation;
(TANS); VLBW 59, 107
Diabetic pregnancy; Perinatal mortality 59, 61
SIDS; Human infant; Sleep; Prone/supine posi-
Neurologic development; Abnormal neurologic
tion $9, 15]
signs (ANS); AGA; Preterm infants; Recovery
rate; SGA; Transient abnormal neurologic signs
SIDS; Maternal smoking; Autonomic function;
(TANS); VLBW 59, 107
Head-up tilt 59, 209
Newborn; Thrombopoietin; Fetus 59, |
Skin care; Human milk; Lactoferrin; Neonatal
care; Fungal infections 59, 95
Organ development; Lung development; Termi-
nal bronchiolar duct endings 59, 193
Sleep; Human infant; Prone/supine position;
SIDS 59, 151
Perinatal mortality; Congenital malformation;
Diabetic pregnancy; Neonatal morbidity 59, 61
Sodium excretion; Atrial natriuretic peptide;
Placenta; Tissue factor pathway inhibitor (TFPI); Preterm newborns; Extracellular fluid volume
Tissue factor (TF); Fetus; Coagulation 59, 77 59, 201
Pre-term; Morphine; Morphine-6-glucuronide; Sudden Infant Death syndrome; Gastro-
Respiration 59, 27 oesophageal reflux; Apparent life-threatening
events 59, 127
Prematurity; Motor development; Risk factor;
Walking 59, 159 Terminal bronchiolar duct endings; Organ
development; Lung development 59, 193
Prenatal attachment; Maternal role; Maternal
sensitivity; Mother—infant interaction 59, 13 Thrombopoietin; Fetus; Newborn 59, |
Subject index 223
Tissue factor (TF); Tissue factor pathway inhib- Very low birth weight; Neonatal blood pressure;
itor (TFPI); Fetus; Placenta; Coagulation 59, 77 Intracranial hemorrhage; Antenatal steroids; Vol-
ume expansion; Pressor therapy 59, 37
Tissue factor pathway inhibitor (TFPI); Tissue
factor (TF); Fetus; Placenta; Coagulation 59, 77 Very preterm infants; Development; Follow-up;
Disorders 59, 175
Transient abnormal neurologic signs (TANS);
Abnormal neurologic signs (ANS); AGA; Neuro- Volume expansion; Neonatal blood pressure;
logic development; Preterm infants; Recovery Very low birth weight; Intracranial hemorrhage;
rate; SGA; VLBW $9, 107 Antenatal steroids; Pressor therapy 59, 37
VLBW; Abnormal neurologic signs (ANS); Walking; Motor development; Prematurity; Risk
AGA; Neurologic development; Preterm infants; factor 59, 159
Recovery rate; SGA; Transient abnormal neuro-
logic signs (TANS) 59, 107